TrialHepatology international2015

Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide.

Po-Chin Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.